our quarter the XXXX. full you, and and joining business call update for everyone, fourth Thank Ezgi, thanks, year for
and approval Inspire of which compatibility; important device XX,XXX of year the France; milestones, approval, of medical our regulation the reimbursement filled therapy, Inspire included FDA including U.S. country-wide was with MRI the full surpassing XXXX neurostimulator; approval profitability. XXX first Union V peer-reviewed full exceeding European publications; treated in with patients many body
change Kelly, leadership quality We new and of our expanded of to marketing who U.S. and fueling continue our Jason teams. sales to future Growth our role assumed strengthen Strategy Chief Chief was organizational We the Quality Weatherby and team recently growth. Manufacturing the Carlton Officer, promoted and will lead Officer announced regulatory aimed chain, supply at created an and the to newly transitioned Randy and Patient assurance medical is teams. clinical society leadership and focus the to another Ban with by The our key outcomes communications organization Access continue role year teams. team execution energized of evidence Development, and also relationships. tasked therapy and a in of will and we and look international on enhancing enhancements, lead strong these XXXX. research leading development Executive increasing access, forward patient Vice new leader our to of President Therapy and opinion welcome Randy
in the that we of revenue quarter Earlier compared a the representing XXXX. fourth million, increase generated XX% of $XXX.X year, to preannounced we
to that $XXX we improve XXXX. compared in XXXX in full share per generated income in profitability of we year XXXX. XXXX. was quarter XX% represented share period, representing per of of our with net the our are in our a Given diluted profitability net the loss to income million first million diluted year, $XX.X XX% of for full of this, to we excited XXXX $XXX in cash the year $X.XX With income revenue flow prior year-over-year. and million quarter the Further, million, million operating fourth performance, of share to was $X.XX compared we for guidance announce to full to strong reiterating year growth are per $XX.X $XXX $X.XX $X.XX to fourth plan Net compared
the in in such, share. expect As XXXX, income $X.XX be we to net $X.XX per range to of diluted
fewer you Inspire the designed V benefit Inspire the neurostimulator, enhancements, sleep the surgical to activation the that physician of and future capability tracking. lead. This device with neurostimulation the in to patient feature A to production system. the implant with it component and performance reduced for company device provide and is As provides is cost. key the need the Further, XXXX, to sleep sensing auto feature the the internal for approval V detection one for time including eliminating to to pressure we FDA incorporates know, received respiratory with reduced V complexity software-based sensing Inspire
implanted been with positive. systems in the device both Inspire We and V in experience early have and U.S., gained Singapore with the already valuable has feedback
the are with of U.S. experience further primary the expected we full move and sites at market procedures gain will during continue as in release limited with to timing our the our we continuing towards in The to U.S. We the inventory support the factor V building launch launch demand additional sufficient year. driving remains Inspire U.S., full
was professional of We few be IV specifically that procedures cases. the pressure stimulation and only system, date, namely ago authorization current approval CPT the of performed neural used Inspire incorporated in will lead. in and V Inspire XXXX code years reflects emphasize XXXXX cases elimination to implanting appropriately code in CPT describes code years utilized by prior used the to our and the X sensing to The carriers. since for Inspire For insurance was accurately with the want code originally XXXXX stimulator and X all CPT the the XXXXX fee procedure, X all received work the reduced implanting CPT V XXXXX the from lead. U.S. first Inspire continue a
additional sensing reduction up with will of and and not surgeons for procedure encourage Inspire reimbursement with comfort a it discomfort where believe free rate sensing for Inspire been basis. surgeons placement benefits will typically surgeon result The placing the Inspire source in long ENT of comparable has therapy. as Further, not perform V is We the in to time-adjusted cases confidence the lead associated the more on a time will surgical operate. the of to surgical time adopt a believe they surgeon lead the we resulting surgeon
SleepSync screens. log feature provide of may access upgrade, longer operational or care programming tablet this system in is is their laptops to programming system health States. Inspire provide access is further data A no new the assist laptop goal the the decision-making. efficient With United and launched to the to improved to and required providers reducing for new care key in patient complexities. this their SleepSync patient system in to that programming utilize has fully more tablets, Inspire been The provider or health The own simply
The ENT in primary development and continue capacity focus demand our and the fellows to both meet With our in to market continue see to we of to XXX we practice medical training improve respect and hosted advanced our to we Inspire ENT APP, at strong therapy. advance programs. for providers, clinics or provider, sleep activities, XXX initiative sleep education practice is advanced XXXX, patient XXX residents programs, over Inspire
broad therapy for with care provide as and Inspire offers care in In and education of XXXX, conferences, patients ongoing continuing we advancements initiating resident, care a we to We medical website programs, marketing continued therapy plan to medical health training, and our increase fellowship in well our and awareness a support awareness Inspire and adoption participation primary provider a pathway care. program. cardiology focus primary patient cardiology to education are connect our through program and to and in the APP as deliver adviser that education programs the including making
advertising In strategy, XXXX, lower cost. we be a with goal designed of invest targeted. example of Inspire our a to significant further marketing robust has connect outreach our and with programs which patient's a to plan contributed one ability And in In and patient the increase therapy awareness enhancing at in with programs to beyond, our digital care XXXX we health engagement to improving more continue is to patient a provider.
behalf to example patients. exciting submit online with have is prospective appointment tool, used the using experience Advisor centers currently improve in XXXX. plan expand care and this Care providers on by tool qualified our of An to to to Program scheduling, program We digital requests this we directly health electronic patient XXX an
we updating policies FDA commercial On label. our to expanded payer front, continue progress the to make access our market
assisting we provide have regard, patient facilitate Inspire obtaining in team to prior ability steadily from this this we Additionally, by prior to to therapy patients expanded authorization our authorization access In our coverage payers. decisions enhance assistance.
provide intend On cooperate and Before a the CID Rick, the the our reimbursement call products. to one would demand XX, civil relating and I update. practices Justice. January The to we received investigation additional marketing, from to the with the fully We of requests information like Department turn with requested. information to provide I promotion associated investigative over
applicable procedures, committed in business and our and We compliance conducting to of compliance are programs remain confident the and with regulations. we laws our strength ethically and in
we summary, focused In continue therapy. adoption the to growth the remain patient of Inspire and on
We effectively to manage higher of treat driving patients. and strategy increasing will partners of capacity execute quality flow provider patient growth our our and more the
are providers, advanced tools, and objective of Our the increase our capacity. adoption embedded SleepSync Inspire key to commercial practice certifying digital of additional which strategies team's and to include qualified implant therapy all provider adding driving surgeons strategies our and
place ahead, and that strategy stakeholder we long-term have excited are to the future confident we in remain about our value. appropriate Looking drive
his like review I'd our the call that, turn for of financials. over to Rick With to